Literature DB >> 34378928

Strong Hydration Ability of Silk Fibroin Suppresses Formation and Recrystallization of Ice Crystals During Cryopreservation.

Qingrui Fan1, Mengjia Dou2,3,4, Junqiang Mao1, Yi Hou2,3,5, Shuo Liu1, Lishan Zhao6, Jianyong Lv6, Zhang Liu1, Yilin Wang1, Wei Rao2,3,5, Shenglin Jin1,6, Jianjun Wang1,5,6.   

Abstract

The cryopreservation (CP) of cell/tissue is indispensable in medical science. However, the formation of ice during cooling and ice recrystallization/growth in time of thawing present significant risk of cell/tissue damage upon analysis of CP process. Herein, the natural and biocompatible silk fibroin (SF) with regular hydrophobic and hydrophilic domains, were first employed as a cryoprotectant (CPA), to the CP of human bone-derived mesenchymal stem cells (hBMSCs), which has been routinely cyropreserved for cell-based therapies. Addtion of SF can regulate the formation of ice crystals during cooling process because of its strong hydration ability in the comparation to the cryopreservation medium (CM) without SF. Moreover, the devitrification-induced recrystallization/growth of ice during the thawing process is suppressed. Most importantly, the addition of 10 mg mL-1 SF can achieve 81.28% cell viability of cryopreserved hBMSCs as similar as those with the addition of 180 mg mL-1 Ficoll 70 (commercial CPA), and the functions of the cryopreserved hBMSCs are maintained as good as that of the fresh ones. This work is not only significant for meeting the ever-increasing demand of cell therapy, but also trailblazing for designing materials in controlling ice formation and growth during the CP of other cells and tissues.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34378928     DOI: 10.1021/acs.biomac.1c00700

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  1 in total

Review 1.  Improving Cell Recovery: Freezing and Thawing Optimization of Induced Pluripotent Stem Cells.

Authors:  Markus Uhrig; Fernando Ezquer; Marcelo Ezquer
Journal:  Cells       Date:  2022-02-24       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.